Search results
Antithrombin & Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human AT/HCII deficient plasma is required.
Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human heparin cofactor II deficient plasma is required.
Imidazole buffer pH 7.30
Buffer for clotting assays (plasma samples). Diluent for plasma
Factor II (Prothrombin), anti-human, mouse, IgG
LIAPHEN Antithrombin
Assay of AT in human citrated plasma.
FIBRIPHEN™ LRT
Clotting method for quantitative determination of fibrinogen (Clauss method)
HEMOCLOT Thrombin Time LRT
In vitro qualitative determination of thrombin time in human citrated plasma, using a manual or automated method.
CRYOcheck Chromogenic Factor VIII, frozen
Intended to be used as an aid in the management of hemophilia A in individuals aged two years or older. With a limit of quantification of 0.5% FVIII activity and a test range of 0–200% FVIII using one standard curve, CRYOcheck Chromogenic Factor VIII provides very good assurance in results, especially in cases of patients with severe hemophilia A.
Calcium Chloride
Coagulation assays, such as the Activated Partial Thromboplastin Time (APTT) or for the assays of factors of the intrinsic coagulation pathway.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.